Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Serum folate forms are stable during repeated analysis in the presence of ascorbic acid and during frozen sample storage

Filetype[PDF-864.12 KB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Alternative Title:
      J Appl Lab Med
    • Personal Author:
    • Description:
      Background:

      Serum folate forms and particularly tetrahydrofolate are sensitive to oxidation.

      Methods:

      Using a repeated measures design, we investigated the stability of folate forms in convenience samples with added ascorbic acid (AA, 5 g/L) analyzed initially and after variable (~1–33 weeks) storage time at -70°C. We examined the recovery of tetrahydrofolate added at different spiking levels to serum with and without AA (5 g/L). We also assessed the long-term frozen storage stability of folate forms.

      Results:

      Repeat analysis produced consistent results with the initial analysis; the mean relative change (95% CI; Lin’s concordance correlation between initial and repeat result; sample size) was 0.08% (-0.24% to 0.39%; rc=0.999; n=301) for 5-methyltetrahydrofolate; 4.23% (2.44% to 6.05%; rc =0.984; n=211) for pyrazino-s-triazine derivative of 4α-hydroxy-5-methyltetrahydrofolate (MeFox); -0.22% (-1.90% to 1.49%; rc =0.986; n=214) for folic acid; and 1.49% (-2.71% to 5.88%; rc =0.889; n=81) for tetrahydrofolate. Linear regression testing for a time trend indicated an estimated average percent change of <±5% for samples retested after 4 months: 5-methyltetrahydrofolate Ptrend=0.0007, folic acid Ptrend <0.0001, MeFox Ptrend =0.38, and tetrahydrofolate Ptrend =0.0256. The mean±SD tetrahydrofolate spiking recovery was 96.7%±9.4% for serum with added AA, but <50% for serum without added AA. We observed ≤10% loss for most serum folate forms during 4 years of storage at -70°C.

      Conclusions:

      Serum containing added AA showed acceptable stability of folate forms during repeat analysis from the same vial within 4 months, complete spiking recovery of tetrahydrofolate during sample processing, and long-term frozen storage stability of folate forms.

    • Subjects:
    • Source:
      J Appl Lab Med. 3(6):993-1002
    • Pubmed ID:
      31639690
    • Pubmed Central ID:
      PMC7263443
    • Document Type:
      Journal Article
    • Funding:
      CC999999/ImCDC/Intramural CDC HHS/United States
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov